It is also known that MYC is an IKZF1 target gene [8]; thus, CK2 inhibitor acts as an IKZF1 activator and suppresses MYC expression in an IKZF1-dependent manner in ALL cells [8]. Here, IKZF1 is linked to acute lymphoblastic leukemia.